UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Two well-differentiated pancreatic neuroendocrine tumor mouse models

Cell death and differentiation, 2020-01, Vol.27 (1), p.269-283

2020

Volltextzugriff (PDF)

Alleles of Insm1 determine whether RIP1-Tag2 mice produce insulinomas or nonfunctioning pancreatic neuroendocrine tumors

Oncogenesis (New York, NY), 2019-02, Vol.8 (3), p.16-16, Article 16

2019

Volltextzugriff (PDF)

A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum

Endocrine-related cancer, 2011-02, Vol.18 (1), p.171-180

2011

Volltextzugriff (PDF)

Abstract 267: Preclinical investigation of the HSP90 inhibitor, ganetespib, in combination with FDA-approved cytotoxic agents for their potential anti-tumor effects on human neuroendocrine tumors

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.267-267

2016

Volltextzugriff (PDF)

Abstract 1538: A mouse model that mimics human MEN1 tumor is effective in preclinical neuroendocrine tumor therapeutics

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1538-1538

2017

Volltextzugriff (PDF)

High-throughput image analysis of tumor spheroids: a user-friendly software application to measure the size of spheroids automatically and accurately

Journal of visualized experiments, 2014-07 (89)

2014

Volltextzugriff (PDF)

Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1 , Trp53 , Men1 , and Pten in neuroendocrine tumors in mice

Oncotarget, 2020-07, Vol.11 (28), p.2718-2739

2020

Volltextzugriff (PDF)

Abstract 4254: Human neuroendocrine Bon 1 cells as a three-dimensional model for the study of human neuroendocrine tumor therapy

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.4254-4254

2012

Volltextzugriff (PDF)

Abstract 3185: Complement C5 promotes male bias of pancreatic neuroendocrine tumor metastasis

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3185-3185

2015

Volltextzugriff (PDF)

Heat shock protein 90 is a promising target for effective growth inhibition of gastrointestinal neuroendocrine tumors

International journal of oncology, 2012-05, Vol.40 (5), p.1666-1674

2012

Volltextzugriff (PDF)

Human neuroendocrine tumor cell lines as a three-dimensional model for the study of human neuroendocrine tumor therapy

Journal of visualized experiments, 2012-08 (66), p.e4218-e4218

2012

Volltextzugriff (PDF)

P53 mutations in lymphomas: position matters

Blood, 2008-10, Vol.112 (8), p.2997-2998

2008

Volltextzugriff (PDF)

High-throughput Image Analysis of Tumor Spheroids: A User-friendly Software Application to Measure the Size of Spheroids Automatically and Accurately

Journal of visualized experiments, 2014-07 (89)

2014

Volltextzugriff (PDF)

Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis : Survival and responses in 25 patients

Blood, 1998-05, Vol.91 (10), p.3662-3670

1998

Volltextzugriff (PDF)

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Journal of visualized experiments, 2012-08 (66)

2012

Volltextzugriff (PDF)

Abstract A215: Hsp90 inhibitor IPI-504 demonstrates antitumor activity against a panel of neuroendocrine/carcinoid cell lines in vitro and in vivo

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.A215-A215

2009

Volltextzugriff (PDF)

Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis : One-year follow-up in five patients

Blood, 1996-10, Vol.88 (7), p.2801-2806

1996

Volltextzugriff (PDF)

Intermediate‐dose intravenous melphalan and blood stem cells mobilized with sequential GM+G‐CSF or G‐CSF alone to treat AL (amyloid light chain) amyloidosis

British journal of haematology, 1999-03, Vol.104 (3), p.553-559

1999

Volltextzugriff (PDF)

Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding

Blood, 1993-05, Vol.81 (9), p.2357-2362

1993

Volltextzugriff (PDF)

Pulmonary leukostasis secondary to all-trans retinoic acid in the treatment of acute promyelocytic leukemia in first relapse

Leukemia, 1992-06, Vol.6 (6), p.608-610

VOSBURGH, E

1992

Volltextzugriff (PDF)

Pruritus secondary to hydroxyurea therapy in a woman with polycythemia vera

American journal of hematology, 1992-09, Vol.41 (1), p.70-70

Vosburgh, Evan

1992

Volltextzugriff (PDF)

Tiazofurin effects on IMP-dehydrogenase activity and expression in the leukemia cells of patients with CML blast crisis

Anticancer research, 1996-11, Vol.16 (6A), p.3349

1996

Volltextzugriff (PDF)

Phase I trial of the colloidal dispersion formulation of 9-amino-20(S)-camptothecin administered as a 72-hour continuous intravenous infusion

Clinical cancer research, 1998-02, Vol.4 (2), p.317-324

1998

Volltextzugriff (PDF)

Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura

British journal of haematology, 1989-05, Vol.72 (1), p.68-72

1989

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(33)
Tagungsberichte
(2)

Sprache

Englisch
(35)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Humans
(19)
Life Sciences & Biomedicine
(19)
Male
(13)
Biological And Medical Sciences
(12)
Medical Sciences
(11)
Female
(10)
Middle Aged
(10)
Hematology
(8)
Oncology
(7)
Adult
(6)
Aged
(5)
Pharmacology. Drug Treatments
(5)
Antineoplastic Agents
(4)
Neuroendocrine Tumors - Pathology
(4)
Amyloidosis - Therapy
(3)
Animals
(3)
Hematologic And Hematopoietic Diseases
(3)
Melphalan - Administration & Dosage
(3)
Neuroendocrine Tumors
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Two well-differentiated pancreatic neuroendocrine tumor mouse models

Alleles of Insm1 determine whether RIP1-Tag2 mice produce insulinomas or nonfunctioning pancreatic neuroendocrine tumors

A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum

Abstract 267: Preclinical investigation of the HSP90 inhibitor, ganetespib, in combination with FDA-approved cytotoxic agents for their potential anti-tumor effects on human neuroendocrine tumors

Abstract 1538: A mouse model that mimics human MEN1 tumor is effective in preclinical neuroendocrine tumor therapeutics

High-throughput image analysis of tumor spheroids: a user-friendly software application to measure the size of spheroids automatically and accurately

Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1 , Trp53 , Men1 , and Pten in neuroendocrine tumors in mice

Abstract 4254: Human neuroendocrine Bon 1 cells as a three-dimensional model for the study of human neuroendocrine tumor therapy

Abstract 3185: Complement C5 promotes male bias of pancreatic neuroendocrine tumor metastasis

Heat shock protein 90 is a promising target for effective growth inhibition of gastrointestinal neuroendocrine tumors

Human neuroendocrine tumor cell lines as a three-dimensional model for the study of human neuroendocrine tumor therapy

P53 mutations in lymphomas: position matters

High-throughput Image Analysis of Tumor Spheroids: A User-friendly Software Application to Measure the Size of Spheroids Automatically and Accurately

Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis : Survival and responses in 25 patients

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Abstract A215: Hsp90 inhibitor IPI-504 demonstrates antitumor activity against a panel of neuroendocrine/carcinoid cell lines in vitro and in vivo

Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis : One-year follow-up in five patients

Intermediate‐dose intravenous melphalan and blood stem cells mobilized with sequential GM+G‐CSF or G‐CSF alone to treat AL (amyloid light chain) amyloidosis

Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding

Pulmonary leukostasis secondary to all-trans retinoic acid in the treatment of acute promyelocytic leukemia in first relapse

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma : an international collaborative study. Commentary

Pruritus secondary to hydroxyurea therapy in a woman with polycythemia vera

Tiazofurin effects on IMP-dehydrogenase activity and expression in the leukemia cells of patients with CML blast crisis

Phase I trial of the colloidal dispersion formulation of 9-amino-20(S)-camptothecin administered as a 72-hour continuous intravenous infusion

Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura

Suchergebnisse filtern